Douglas K. Graham, MD, PhD
Project title
“Novel biologically targeted therapy against the Mer receptor tyrosine kinase in the treatment of pediatric ALL”
Institution
University of Colorado Denver
Named Award
Damon Runyon-Novartis Clinical Investigator